Aviron Message Board - Msg: 16138286

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aviron

AVIR 3.240

-0.9%

Oct 31 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ChinuSFO who started this subject	7/27/2001 6:06:07 PM
From: sim1	of 645

Aviron says won't launch FluMist for 2001 season Friday July 27, 4:41 pm Eastern Time GAITHERSBURG, Md., July 27 (Reuters) - Aviron(NasdaqNM:AVIR - news) will not be able to launch its FluMist nasal spray vaccine in time for the upcoming flu season, the pharmaceutical company's chief executive said on Friday after a U.S. regulatory panel voted against recommending approval of FluMist, citing safety concerns. ``We will not be able to launch this vaccine in time to participate in the 2001-2002 flu season,'' Aviron Chairman and Chief Executive Boyd Clarke told reporters after a Food and Drug Administration (FDA) advisory committee voted against recommending approval for FluMist to prevent influenza because members were not convinced of the product's safety. Clarke said making limited quantities of FluMist available had been a secondary objective for Aviron, based in Mountain View, Calif. ``Our primary objective still remains securing licensure of this vaccine in order to participate in a full launch for FluMist in 2002,'' Clarke said.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next